Has Jon Dvorak received payments from drug or device companies?

Yes. Drug and device makers reported $212,108 in general payments to Jon Dvorak across 392 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jon Dvorak did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jon Dvorak come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jon Dvorak

Pediatrics · Perrysburg, OHNPI 1205828241

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $177,375 of the $212,108 with a category attached, or 83.6%. GSK accounts for 98.6% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2023 at $74,204 and has fallen 77.3% since, to $16,859 in 2025. Among pediatrics clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$212,108in general payments, 2019–2025

Across 392 payments — averaging $541.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GSK$209K
Merck$510
Pfizer$403
Corium, LLC$363
Ironshore Pharmaceuticals Inc.$289
Kaleo, Inc.$278
plus $1K from 21 others

What the payments were for

Speaking & faculty fees$177,37584%
Travel & lodging$26,33112%
Food & beverage$8,3824%
Education$200%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GSK	228	$209,126
Merck	23	$510
Pfizer	20	$403
Corium, LLC	21	$363
Ironshore Pharmaceuticals Inc.	15	$289
Kaleo, Inc.	18	$278
Neos Therapeutics, LP	10	$145
Sanofi Pasteur Inc.	6	$131
Takeda Pharmaceuticals U.S.A., Inc.	9	$121
Tris Pharma Inc	7	$121
Supernus Pharmaceuticals, Inc.	5	$112
Phadia US Inc.	6	$91
Sanofi	3	$57
Pacira Pharmaceuticals Incorporated	2	$40
Seqirus USA Inc	2	$35
Collegium Pharmaceutical, Inc.	2	$34
Vertical Pharmaceuticals, LLC	2	$33
Avion Pharmaceuticals	2	$31
Cipher Pharmaceuticals US LLC	1	$28
Adlon Therapeutics L.p.	2	$25
Sobi, Inc	2	$25
Novartis	1	$21
AstraZeneca	1	$20
Aytu Biopharma, Inc.	1	$19
Roche Diagnostics Corporation	1	$19
Mission Pharmacal Company	1	$16
Novo Nordisk	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

BEXSERO$190,878
PENMENVY$15,265

How this compares

$212,108 in reported general payments places this provider in the 95th percentile of 2,041 pediatrics providers in Ohio.

See all pediatrics providers in Ohio →

Other pediatrics in Perrysburg

Tracy KarolyiPerrysburg$4K
Eric RaderPerrysburg$4K
Charles DebrosseCincinnati$135K
Scott WexelblattCincinnati$64K
Breanne RocheSolon$58K
Richard BreenHilliard$43K
Catherine McDanielDayton$34K
Lisa RichardsToledo$31K
Kristie RossCleveland$20K
Jessica CastonguayAkron$18K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →